New Personalized Cancer Vaccine Manufacturing Site Opens in Minnesota

May 11, 2011
The new production space will accommodate manufacturing for Biovest's late-stage, autologous, active immunotherapy for the treatment of non-Hodgkin's lymphoma.

Biovest International, Inc. announced on May 11 that construction has been completed its new BiovaxID-dedicated production suites. It is part of an expansion project within Biovest's 35,000 sq. ft. cell culture center in Coon Rapids, a suburb of Minneapolis.

Funding was provided by a public/private partnership with the State of Minnesota, the City of Coon Rapids and JMS Holdings, LLC.

This new production space will accommodate manufacturing for Biovest's late-stage, autologous, active immunotherapy for the treatment of non-Hodgkins lymphoma. BiovaxID was developed in collaboration with the National Cancer Institute, and Biovest is currently preparing for meetings with U.S. and international regulatory agencies to discuss the next steps in seeking approvals for BiovaxID based on positive Phase III clinical trial results.

"This is a key milestone as we are initiating the commissioning and validation processes with the facility currently undergoing comprehensive testing and review to ensure that the BiovaxID manufacturing 'clean rooms' are consistent with our standards of operational excellence and will satisfy the regulatory criteria of an FDA inspection," said Biovests President, Samuel S. Duffey. "Furthermore, I expect we will be producing BiovaxID vaccines in this new facility sometime this summer."

Popular Sponsored Recommendations

New Product Development Checklist

May 30, 2023
The average ROI of rigorous new product development research is 1,500%. Learn how to conduct the research you need to ensure a successful NPD process.

Digital Production Tracking: How Connected Platforms with No-Code Deliver Value

Sept. 19, 2023
Manual tracking lacks the real-time visibility manufacturers need to identify root causes and remain competitive. Digital, connected production tracking is crucial for your operations...

Why DataOps may be the key to unlocking the full potential of digital transformation

Nov. 3, 2023
Read the 2023 market survey conducted by IndustryWeek

Process Mining For Dummies

Nov. 19, 2023
Here it is. Everything you need to know about process mining in a single book, written in the easy-to-understand, hard-to-forget style that ‘For Dummies’ manages so effortlessly...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!